Duration of Upfront Immunotherapy for NSCLC – OncLive
OncLive |
Duration of Upfront Immunotherapy for NSCLC
OncLive Everett Vokes, MD: We’ve covered a lot of the key studies. There are a lot of unanswered questions, of course. We covered where PD-L1-negative or low expressers fall into this, and we’re waiting for more data. Another issue is the duration of therapy … |
Multiple Sclerosis News Today |
MS Gene Therapy Shows Good Results in Mice, but Human Trials Remain Distant
Multiple Sclerosis News Today Researchers have taken the first steps towards the development of a gene therapy for multiple sclerosis — a treatment that boosted anti-inflammatory immune processes and reversed severe paralysis in mouse models of the disease. The University of … New gene therapy prevents MS and reverses paralysis in miceNew Atlas |
|
Chemistry Nobel predictions range from perovskites to Crispr
Chemistry World (subscription) As excitement builds once more, analysts and online commentators are making their predictions on who they think has a chance of securing science’s top gong, with suggestions ranging from Crispr to heterogeneous catalysis and perennial also-ran the … |